135 related articles for article (PubMed ID: 2112552)
1. Endocrine responses to gonadotrophins after LHRH agonist administration on cycle days 1-4: prevention of premature luteinization.
Martikainen H; Rönnberg L; Tapanainen J; Puistola U; Orava M; Kauppila A
Hum Reprod; 1990 Apr; 5(3):246-9. PubMed ID: 2112552
[TBL] [Abstract][Full Text] [Related]
2. Human prolactin release induced by follicle stimulating hormone, luteinizing hormone and human chorionic gonadotrophin.
Crosignani PG; Maini MC; Negri E; Ragni G
Hum Reprod; 1991 Sep; 6(8):1070-3. PubMed ID: 1806563
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles.
Norman RJ; Warnes GM; Wang X; Kirby CA; Matthews CD
Hum Reprod; 1991 Feb; 6(2):206-13. PubMed ID: 1905309
[TBL] [Abstract][Full Text] [Related]
4. Comparison between prolactin, gonadotrophins and steroid hormones in serum and follicular fluid after stimulation with gonadotrophin-releasing hormone agonists and human menopausal gonadotrophin for an in-vitro fertilization programme.
Kamel MA; Zabel G; Bernart W; Neulen J; Breckwoldt M
Hum Reprod; 1994 Oct; 9(10):1803-6. PubMed ID: 7844206
[TBL] [Abstract][Full Text] [Related]
5. Recovery of corpus luteum function after prolonged deprivation from gonadotrophin stimulation.
Weissman A; Loumaye E; Shoham Z
Hum Reprod; 1996 May; 11(5):943-9. PubMed ID: 8671368
[TBL] [Abstract][Full Text] [Related]
6. Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol.
Smitz J; Erard P; Camus M; Devroey P; Tournaye H; Wisanto A; Van Steirteghem AC
Hum Reprod; 1992 Oct; 7(9):1225-9. PubMed ID: 1479002
[TBL] [Abstract][Full Text] [Related]
7. Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH.
Ubaldi F; Camus M; Smitz J; Bennink HC; Van Steirteghem A; Devroey P
Fertil Steril; 1996 Aug; 66(2):275-80. PubMed ID: 8690116
[TBL] [Abstract][Full Text] [Related]
8. Altered follicular development in clomiphene citrate versus human menopausal gonadotropin-stimulated cycles for in vitro fertilization.
Dlugi AM; Laufer N; Botero-Ruiz W; DeCherney AH; Polan ML; Haseltine FP; Mezer HC; Behrman HR
Fertil Steril; 1985 Jan; 43(1):40-7. PubMed ID: 3155509
[TBL] [Abstract][Full Text] [Related]
9. Analysis of hormonal changes during combined buserelin/HMG treatment.
Urbancsek J; Rabe T; Grunwald K; Kiesel L; Runnebaum B
Hum Reprod; 1990 Aug; 5(6):675-81. PubMed ID: 2123882
[TBL] [Abstract][Full Text] [Related]
10. The synergistic effects of clomiphene citrate and human menopausal gonadotrophin in the folliculogenesis of stimulated cycles as assessed by the gonadotrophin-releasing hormone antagonist Nal-Glu.
Cassidenti DL; Paulson RJ; Lobo RA; Sauer MV
Hum Reprod; 1992 Mar; 7(3):344-8. PubMed ID: 1587939
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of pituitary and corpus luteum responses to single intranasal administration of (D-ser[TBU]6-des-gly-NH2(10)) luteinizing hormone-releasing hormone ethylamide (Buserelin) in normal women.
Lemay A; Faure N; Labrie F
Fertil Steril; 1982 Feb; 37(2):193-200. PubMed ID: 6800846
[TBL] [Abstract][Full Text] [Related]
12. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
13. A randomized comparative study of purified follicle stimulating hormone and human menopausal gonadotropin after pituitary desensitization with Buserelin for superovulation and in vitro fertilization.
Bentick B; Shaw RW; Iffland CA; Burford G; Bernard A
Fertil Steril; 1988 Jul; 50(1):79-84. PubMed ID: 3133251
[TBL] [Abstract][Full Text] [Related]
14. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.
Derksen L; Tournaye H; Stoop D; Van Vaerenbergh I; Bourgain C; Polyzos NP; Haentjens P; Blockeel C
Reprod Biomed Online; 2014 Mar; 28(3):359-68. PubMed ID: 24456700
[TBL] [Abstract][Full Text] [Related]
15. Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the late luteal phase in the stumptailed macaque monkey.
Fraser HM; Sandow J
J Clin Endocrinol Metab; 1985 Mar; 60(3):579-84. PubMed ID: 3919049
[TBL] [Abstract][Full Text] [Related]
16. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
Lemay A; Faure N
J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
[TBL] [Abstract][Full Text] [Related]
17. The use of the GnRH analogue buserelin for IVF--does it improve fertility?
Shelton K; Fishel S; Jackson P; Webster J; Faratian B; Johnson J
Br J Obstet Gynaecol; 1991 Jun; 98(6):544-9. PubMed ID: 1908314
[TBL] [Abstract][Full Text] [Related]
18. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropic stimulation of inhibin secretion by the human ovary during the follicular and early luteal phase of the cycle.
Tsonis CG; Messinis IE; Templeton AA; McNeilly AS; Baird DT
J Clin Endocrinol Metab; 1988 May; 66(5):915-21. PubMed ID: 3129450
[TBL] [Abstract][Full Text] [Related]
20. Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?
Lin Y; Kahn JA; Hillensjö T
Hum Reprod; 1999 Apr; 14(4):885-8. PubMed ID: 10221213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
